packageLamivudine

lamivudine

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Lamivudine is an antiviral nucleoside analogue used to treat HIV infection and chronic hepatitis B. It is widely used, appears on the WHO essential medicines list, and is authorised in the European Union for HIV and hepatitis B, often in combination products.

Summary written by glm-5.3-flash from Wikidata Q422631 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:lamivudine
ATC codes:J05AF05
DrugBank:DB00709
PubChem CID:60825
ChEBI:63577
Wikidata:Q422631
formula:C8H11N3O3S
molar mass:229.254 g/mol (PubChem CID 60825)
logP:-0.9 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown